期刊文献+

硫酸葡聚糖/重组人骨形态发生蛋白-2/壳聚糖纳米微球联合珊瑚羟基磷灰石修复大段骨缺损的成骨化研究 被引量:2

Osteogenesis of dextran sulfate/recombinant human bone morphogenetic protein-2/chitosan nano microspheres combined with coralline hydroxyapafite in repair of large segmental bone defects
原文传递
导出
摘要 目的探讨硫酸葡聚糖/重组人骨形态发生蛋白-2/壳聚糖纳米微球联合珊瑚羟基磷灰石(Ds/rhBMP2/CS/CHA)在修复大段骨缺损中成骨化能力。方法采用离子交联法制备DS/rhBMP2/CS缓释微球,并经冻干吸附到CHA中,将72只新西兰兔随机分为4组,行右桡骨骨缺损的造模,分别将CHA、rhBMP2/CHA、DS/rhBMP2/CS/CHA植入骨缺损区域中并依次命名为CHA组、rhBMP2/CHA组、DS/rhBMP2/CS/CHA组,另设18只动物为空白对照组(只造模,不植入材料)。术后4、8、12周抽血并取材,行血清骨钙素检测,移植骨标本行Micro—CT扫描并计算新生骨体积比,脱钙后行苏木精-伊红染色观察。结果72只动物术后恢复良好,术口未发生感染或移植物暴露。术后12周大体观察DS/rhBMP2/CS/CHA组骨组织的新生骨含量及质量最优,硬度最强,骨缺损区愈合较其他组好。血清学表明各时期DS/rhBMP2/CS/CHA组的血清骨钙素水平明显高于CHA组、rhBMP2/CHA组,差异均有统计学意义(P〈0.05);Micro-CT结果表明DS/rhBMP2/CS/CHA组各时期均可观察到明显的成骨进程,明显的骨皮质和新生的骨髓腔,骨的重建进程最快,材料的降解伴随着骨的重建,DS/rhBMP2/CS/CHA组的新生骨体积水平高于其他组,差异均有统计学意义(P〈0.05);组织学表明各时期DS/rhBMP2/CS/CHA组的组织学形态良好,可见成熟骨皮质和新生骨髓腔,组织学形态好于CHA组和rhBMP2/CHA组。结论DS/rhBMP2/CS/CHA的人造骨材料具备良好的缓释rhBMP2的骨诱导机制,在参与修复大段骨缺损中展现良好的骨修复能力,明显优于单纯CHA和rhBMP2/CHA人造骨材料。 Objective To investigate the osteogenic ability of dextran sulfate/recombinant human bone morphogenetic protein-2/chitosan (DS/rhBMP2/CS) nano microspheres combined with coralline hy- droxyapatite (CHA) in repair of segmental bone defects. Methods DS/rhBMP2/CS microspheres pre- pared by ionic crosslinking method were adsorbed into CHA by lyophilization. Seventy-two New Zealand rabbits were randomly divided into 3 equal groups after they had been made into models of bone defect at the right radius. The defects in the 3 groups were implanted respectively with CHA, rhBMP2/CHA and DS/rhBMP2/ CS/CHA. Another 18 animals served as a blank control group. Blood and bone samples were obtained at 4, 8 and 12 weeks after implantation. The serum BGP was detected, and the bone grafts were scanned by micro-CT for calculation of volume ratio of the new bone. Hematoxylin and eosin (HE) staining was performed after bone decalcification. Results All the 72 animals recovered well without any infection or graft exposure. Gross observation at postoperative 12 weeks showed that the DS/rhBMP2/CS/CHA group was the best in the quality, quantity and strength of the new bone, as well as in the healing of bone defects. The serum levels of bone gamma-carboxyglutamic-acid-eontaining protein at all time points in the DS/rhBMP2/CS/CHA group were significantly higher than those in the CHA and rhBMP2/CHA groups (P 〈 0. 05). Miero-CT scanning demonstrated obvious progress in bone formation, cortical bone and marrow cavity at all time points in the DS/ rhBMP2/CS/CHA group which showed significantly faster bone reconstruction synchronized with material degradation and significantly higher volume ratio of the new bone than the other 2 groups ( P 〈 0. 05). His- tological examinations showed better morphology of mature cortical bone and new marrow cavity at all time points in the DS/rhBMP2/CS/CHA group than in the other 2 groups. Conclusion Since DS/rhBMP2/ CS/CHA possesses a better mechanism of sustained-releasing rhBMP2 to induce bone formation because of its reticular and hole-hole-connected structure, it may perform better in repairing segmental bone defects than simple CHA or rhBMP2/CHA.
出处 《中华创伤骨科杂志》 CAS CSCD 北大核心 2017年第12期1074-1080,共7页 Chinese Journal of Orthopaedic Trauma
基金 国家自然科学基金青年基金(51303031) 广州市科技计划项目(201607010268,2013J4100120)
关键词 壳聚糖 羟基磷灰石 葡聚糖类 人重组形态发生蛋白-2 骨缺损 Chitosan Hydroxyapatite Glucans Recombinant human morphogenetie protein-2 Bone defect
  • 相关文献

参考文献2

二级参考文献30

  • 1Sullad AG, Manjeshwar LS, Aminabhavi TM, et al. Novel semi-interpenetrating microspheres of dextran-grafted- acrylamide and poly (vinyl alcohol) for controlled release of abaeavir sulfate[J]. Industr Engin Chem Res, 2011, 50, 11778-11784.
  • 2GB/T16175.1996fICS071000.10c-48)中华人民共和国国家标准:医用有机硅材料生物学评价实验方法[s].
  • 3Jun SH, Lee E J, Jang TS, et al. Bone morphogenic protein-2 (BMP-2) loaded hybrid coating on porous hydroxyapatite scaffolds for bone tissue engineering [J]. J Mater Sci Mater Med, 2013, 24(3): 773-782.
  • 4Park JS, Yang HN, Jeon SY, et al. Osteogenic differentiation of human mesenchymal stem cells using RGD-modified BMP-2 coated micropheres [J]. Biomaterials, 2010, 31(24): 6239-6248.
  • 5Valdes MA, Thakur NA, Namdari S, et al. Recombinant bone morphogenic protein-2 in orthopaedic surgery: a review [J]. Arch Orthop Tramna Surg, 2009, 129(12): 1651-1657.
  • 6Bose S, Roy M, Bandyopadhyay A. Recent advances in bone tissue engineering scaffolds [J]. Trends Biotechnol, 2012, 30 (10): 546-554.
  • 7Nitta SK, Numata K. Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering [J]. Int J Mol Sci, 2013, 14(1): 1629-1654.
  • 8Palazzo B, Gallo A, Casillo A, et al. Fabrication, characterization and cell cultures on a novel composite chitosan-nano-hydroxyapatite scaffold [J]. Int J lmmunopathol Pharmacol. 2011.24(1 Su!ol 2): 73-78.
  • 9Cheburu CN, Stoica B, Neamtu A, et al. Bioeompatibility testing of chitosan hydroge|s[J]. Rev Med Chir Soc Med Nat Iasi, 2010, 115: 864-870.
  • 10Antunes JC, Pereira CL, Molinos M, et al. Layer-by-layer self-assembly of ehitosan and poly(y-glutamic acid) into polyelec- trolyte complexes[J]. Biomacromolecules, 2011, 12: 4183-4195.

共引文献4

同被引文献26

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部